Healace Gel contains Recombinant Human Epidermal Growth Factor (100 mcg/gm) and is indicated for the promotion of wound healing and tissue regeneration. This topical formulation facilitates the repair of damaged skin by stimulating cellular proliferation and differentiation, thereby accelerating the natural healing process. Recombinant Human Epidermal Growth Factor acts by binding to specific epidermal growth factor receptors on the surface of keratinocytes and fibroblasts, promoting migration and proliferation essential for re-epithelialization and granulation tissue formation. Healace Gel is commonly used in the management of acute and chronic wounds, including burns, ulcers, surgical incisions, and minor abrasions. Its application results in enhanced epithelialization, reduced healing time, and improved quality of the regenerated tissue. The gel base ensures easy and uniform application, providing a moist wound environment conducive to healing while protecting the wound from external contaminants. Healace Gel should be applied topically to the affected area once or twice daily, as directed by a healthcare professional. Contraindications include hypersensitivity to any component of the formulation. Use with caution in patients with active malignancies at the wound site. Adverse reactions are rare but may include local irritation or allergic response. Consult a healthcare provider for appropriate use and monitoring.